Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on FDA ’s ongoing investigation into valsartan impurities and recalls and an update on FDA’s current findings

FDA update on the ongoing investigation into valsartan impurities, recalls and current findings.

Source: Food and Drug Administration - August 30, 2018 Category: American Health Source Type: news